To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Amendment #76-753-1 with DiaSorin Inc.
?Recommendation of the County Administrator ? Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County Contract Amendment Agreement #76-753-1 with DiaSorin Inc., a corporation, effective March 15, 2024, to amend Contract #76-753, to increase to the payment limit by $21,950, from $495,000 to a new payment limit of $516,950, with no change in the original term of June 1, 2021 through May 31, 2026 to add equipment (a Liaison XL LAS (kit)) to the Product Supply Agreement for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) and Health Centers.
FISCAL IMPACT:
Approval of this amendment will result in additional expenditures of up to $21,950 and will be funded as budgeted by the department in FY 2024-26, by 100% Hospital Enterprise Fund I.
BACKGROUND:
This contract meets the medical needs of the County's population by allowing for the upgrade of County systems to improve efficiency in its immunoassay laboratories. The CCRMC Clinical Laboratory uses DiaSorin Inc. for reagents and supplies for patient specimen testing specific to the analyzer used for testing. Among the tests conducted are those for measles, mumps, rubella, and many others. DiaSorin Inc. provides all the supplies needed for such testing. These tests are crucial for patients who suffer from various illnesses. The CCRMC Clinical Laboratory uses the Liaison XL Analyzer, a fully automated chemiluminescence analyzer to complete its sample processing and run antigen-antibody assays. Under this amendment, the parties will add a Liaison XL LAS (kit) to the Product Supply Agreement needed in conjunction with the Liaison XL Analyzer to complete system upgrades and its Beaker project.
On July 27, 2021, the Board of Supervisors approved Contract #76-753 with DiaSorin Inc....
Click here for full text